Yoko S. DeRose

1.9k total citations · 1 hit paper
10 papers, 1.1k citations indexed

About

Yoko S. DeRose is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Yoko S. DeRose has authored 10 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 4 papers in Immunology and 2 papers in Molecular Biology. Recurrent topics in Yoko S. DeRose's work include Cancer Cells and Metastasis (5 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Phagocytosis and Immune Regulation (2 papers). Yoko S. DeRose is often cited by papers focused on Cancer Cells and Metastasis (5 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Phagocytosis and Immune Regulation (2 papers). Yoko S. DeRose collaborates with scholars based in United States. Yoko S. DeRose's co-authors include Alana L. Welm, Guoying Wang, Bryan E. Welm, Yi‐Chun Lin, Leigh Neumayer, Saundra S. Buys, Inge J. Stijleman, Philip S. Bernard, Edward William Nelson and R. Lor Randall and has published in prestigious journals such as Journal of Clinical Investigation, Nature Medicine and Cancer Research.

In The Last Decade

Yoko S. DeRose

10 papers receiving 1.1k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomes

2011 699 citations Yoko S. DeRose, Guoying Wang et al. Nature Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yoko S. DeRose United States	9	699	439	342	172	165	10	1.1k
Franck Assayag France	17	668 1.0×	549 1.3×	388 1.1×	155 0.9×	227 1.4×	35	1.3k
Ludmilla de Plater France	13	458 0.7×	405 0.9×	249 0.7×	121 0.7×	149 0.9×	23	934
Yves Hüsemann Germany	4	716 1.0×	415 0.9×	415 1.2×	75 0.4×	94 0.6×	4	1.0k
Ana Rita Nobre Portugal	16	741 1.1×	647 1.5×	462 1.4×	84 0.5×	119 0.7×	24	1.4k
Bernhard Polzer Germany	16	791 1.1×	405 0.9×	620 1.8×	63 0.4×	106 0.6×	34	1.2k
Evangeline Mose United States	18	551 0.8×	563 1.3×	239 0.7×	80 0.5×	75 0.5×	25	1.2k
Pramudita R. Prasetyanti Netherlands	13	951 1.4×	906 2.1×	504 1.5×	66 0.4×	109 0.7×	14	1.6k
Zhaomei Mu United States	22	752 1.1×	577 1.3×	605 1.8×	55 0.3×	176 1.1×	43	1.3k
Marlous Hoogstraat Netherlands	14	671 1.0×	638 1.5×	520 1.5×	55 0.3×	172 1.0×	25	1.5k
Kazuharu Kai Japan	18	577 0.8×	487 1.1×	443 1.3×	43 0.3×	187 1.1×	38	1.2k

Countries citing papers authored by Yoko S. DeRose

Since Specialization

Citations

This map shows the geographic impact of Yoko S. DeRose's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoko S. DeRose with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoko S. DeRose more than expected).

Fields of papers citing papers by Yoko S. DeRose

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoko S. DeRose. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoko S. DeRose. The network helps show where Yoko S. DeRose may publish in the future.

Co-authorship network of co-authors of Yoko S. DeRose

This figure shows the co-authorship network connecting the top 25 collaborators of Yoko S. DeRose. A scholar is included among the top collaborators of Yoko S. DeRose based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoko S. DeRose. Yoko S. DeRose is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Kovacsovics-Bankowski, Magdalena, Johanna M. Sweere, Natalia Sigal, et al.. (2024). Lower frequencies of circulating suppressive regulatory T cells and higher frequencies of CD4⁺ naïve T cells at baseline are associated with severe immune-related adverse events in immune checkpoint inhibitor-treated melanoma. Journal for ImmunoTherapy of Cancer. 12(1). e008056–e008056. 9 indexed citations

Kovacsovics, Magdalena, Xuechen Wang, Yoko S. DeRose, et al.. (2023). Abstract 2144: Proteomic study reveals predictive biomarkers of immune-related adverse events in melanoma. Cancer Research. 83(7_Supplement). 2144–2144. 1 indexed citations

Scherer, Sandra D., Alessandra I. Riggio, Yoko S. DeRose, et al.. (2021). An immune-humanized patient-derived xenograft model of estrogen-independent, hormone receptor positive metastatic breast cancer. Breast Cancer Research. 23(1). 100–100. 26 indexed citations

Zoeller, Jason J., Veerle W. Daniëls, Krishan Taneja, et al.. (2020). Navitoclax enhances the effectiveness of EGFR-targeted antibody-drug conjugates in PDX models of EGFR-expressing triple-negative breast cancer. Breast Cancer Research. 22(1). 132–132. 26 indexed citations

Sun, Qi, Jacqueline Lesperance, Hiromi I. Wettersten, et al.. (2017). Proapoptotic PUMA targets stem-like breast cancer cells to suppress metastasis. Journal of Clinical Investigation. 128(1). 531–544. 35 indexed citations

Olsen, Sarah Naomi, Ania Wronski, Zafira Castaño, et al.. (2016). Loss of RasGAP Tumor Suppressors Underlies the Aggressive Nature of Luminal B Breast Cancers. Cancer Discovery. 7(2). 202–217. 52 indexed citations

Eyob, Henok, H. Atakan Ekiz, Yoko S. DeRose, et al.. (2013). Inhibition of Ron Kinase Blocks Conversion of Micrometastases to Overt Metastases by Boosting Antitumor Immunity. Cancer Discovery. 3(7). 751–760. 64 indexed citations

DeRose, Yoko S., Keith M. Gligorich, Guoying Wang, et al.. (2013). Patient‐Derived Models of Human Breast Cancer: Protocols for In Vitro and In Vivo Applications in Tumor Biology and Translational Medicine. Current Protocols in Pharmacology. 60(1). Unit14.23–Unit14.23. 170 indexed citations

DeRose, Yoko S., Guoying Wang, Yi‐Chun Lin, et al.. (2011). Tumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomes. Nature Medicine. 17(11). 1514–1520. 699 indexed citations breakdown →

10.

Liu, Xuedong, Ling Zhao, Yoko S. DeRose, et al.. (2011). Short-Form Ron Promotes Spontaneous Breast Cancer Metastasis through Interaction with Phosphoinositide 3-Kinase. Genes & Cancer. 2(7). 753–762. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact